CD69 and metabolic disease: Furthermore, we show that expression of CD69, a putative marker of TCR-linked activation and tissue residence, on CD4+ T cells increases in a stepwise manner from non-diabetic, to pre-diabetic, to diabetic individuals, which may reflect an interaction between cells of the adaptive immune system and adipocytes in the context of metabolic disease.